Global Markets for 3D Cultures and Organoids: Trends Analysis with Forecast
"The market for lab models, 3D cultures, and organoids is rapidly growing, driven by new technology and the need for alternatives to animal testing in research."
BOSTON, March 12, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets is expected to increase from $2.8 billion in 2024 to $5.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
This report explores the global market for laboratory animal models, 3D cultures and organoids, covering major companies, trends, and regional markets. It provides market data from 2023, forecasts through 2029, and analyzes market drivers, restraints, opportunities, and regulatory factors. The report segments the market by type, application, end user, and regions, and analyzes the leading companies and their market shares.
Interesting facts
The market for lab models, 3D cultures, and organoids is driven by 3D technologies that mimic human tissues, reduce the need for animal testing, and improve drug discovery.
Factors contributing to the growth include:
1. Growing Focus on Ethical Alternatives to Animal Testing: There is a growing shift towards ethical alternatives to animal testing, such as 3D cultures and organoids, to make research more humane. These methods offer accurate results while reducing the need for animal use.
2. Increasing Demand for Tumor Modeling and Biobanking: The demand for tumor modeling and biobanking is growing because they help in cancer research and drug development. This increased need is driving the expansion of the market for these technologies.
3. Increasing Adoption of Organoid Technology: Organoid technology is being used more widely for research and drug testing because it closely mimics human organs. This growing adoption is expanding its applications in medical and scientific fields.
Request a Sample Copy of the Report Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
Report Synopsis
Report Metric |
Details |
Base year considered |
2023 |
Forecast period considered |
2024-2029 |
Base year market size |
$2.5 billion |
Market size forecast |
$5.0 billion |
Growth rate |
CAGR of 12.5% for the forecast period of 2024-2029 |
Segments covered |
Animal Model, 3D cell Culture, Applications |
Regions covered |
North America, Europe, Asia-Pacific, Rest of the World, Middle East and Africa, South America |
Countries covered |
The U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Belgium, the Netherlands, Sweden, Russia, China, Japan, Australia, South Korea, India, New Zealand, Singapore, Malaysia, Thailand, Indonesia, South Africa, GCC Countries, Brazil, Argentina, Colombia, Paraguay, Peru |
Market drivers |
• Growing focus on ethical alternatives to animal testing • Increasing demand for tumor modeling and biobanking • Increasing adoption of organoid technology |
This report addresses the following questions:
1. What is the projected market size and growth rate?
The global market for laboratory animal models, 3D cultures, and organoids was valued at $2.5 billion in 2023 and is projected to reach $5.0 billion by the end of 2029.
2. What factors are driving the growth of the market?
The growing focus on ethical alternatives to animal testing, increasing demand for tumor modeling and biobanking, and growing adoption of organoid technology.
3. Which market segments are covered in the report?
This report analyzes the market based by animal model, 3D cell culture, type and application, end user, and region.
4. Which technology segment will be dominant in 2029?
3D cell culture will have the largest share of the market.
5. Which region has the highest share in the market?
The North American market was valued at $1.4 billion in 2023 and is projected to reach $2.9 billion by the end of 2029, at a CAGR of 12.7% during the forecast period.
Market leaders include:
• 3D Biotek LLC
• Bio-Techne
• Cellink
• Charles River Laboratories
• Cherry Biotech
• Corning Inc.
• Emulate Inc.
• Genoway
• Greiner Bio-One International GmbH
• InSphero
• Mattek
• Mimetas B.V.
• Pepgel LLC
• Poietis
• Taconic Biosciences Inc.
• Thewell Bioscience Inc.
• Thermo Fisher Scientific Inc.
Related reports include:
Induced Pluripotent Stem Cells: Global Markets: Induced pluripotent stem cells (iPSCs) are cells that can turn into any type of cell in the body, making them valuable for research and treatments. The global market for iPSCs is growing as they offer new possibilities for personalized medicine and disease research.
3D Cell Cultures: Technologies and Global Markets: 3D cell cultures are lab-grown cells that mimic the structure of real tissues, improving research and drug testing. The global market for these technologies is growing as they offer more accurate results than traditional 2D cultures.
Purchase a copy of the report direct from BCC Research.
For further information on these reports or to purchase one, please contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Share this article